Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?

Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?
复制标题

DOI:
10.18632/oncotarget.19433
复制
发表时间:
2017-10-31
期刊:
影响因子:
--
通讯作者:
Ferreira JA
Ferreira JA
中科院分区:
其他
文献类型:
--
作者:
Azevedo R;Peixoto A;Gaiteiro C;Fernandes E;Neves M;Lima L;Santos LL;Ferreira JA

文献摘要

参考文献

被引文献

相似文献

膀胱肿瘤的高分子异质性是导致病程显著变化以及复发和进展率升高的原因,从而阻碍了更有效的靶向治疗的引入。实施精确的肿瘤学设置支持的强大的分子模型的个性化患者管理是必要的。这项工作需要全面整合大量的泛组学数据,而这一点尚未完全实现。为实现这一目标,40多年的膀胱癌糖生物学研究已经揭示了伴随疾病进展和传播的大量癌症特异性聚糖和糖缀合物(糖蛋白、糖脂、蛋白聚糖)。本文综述了该领域的主要结构研究结果及其生物学和临床意义。鉴于这些分子的细胞表面和分泌性质,我们进一步讨论了它们在非侵入性检测和治疗开发方面的潜力。此外,我们强调新的质谱为基础的高通量分析和生物信息学工具,询问在后基因组时代的糖组。最后,我们概述了一个路线图,以指导未来的发展设想临床实施的糖组学。
The high molecular heterogeneity of bladder tumours is responsible for significant variations in disease course, as well as elevated recurrence and progression rates, thereby hampering the introduction of more effective targeted therapeutics. The implementation of precision oncology settings supported by robust molecular models for individualization of patient management is warranted. This effort requires a comprehensive integration of large sets of panomics data that is yet to be fully achieved. Contributing to this goal, over 40 years of bladder cancer glycobiology have disclosed a plethora of cancer-specific glycans and glycoconjugates (glycoproteins, glycolipids, proteoglycans) accompanying disease progressions and dissemination. This review comprehensively addresses the main structural findings in the field and consequent biological and clinical implications. Given the cell surface and secreted nature of these molecules, we further discuss their potential for non-invasive detection and therapeutic development. Moreover, we highlight novel mass-spectrometry-based high-throughput analytical and bioinformatics tools to interrogate the glycome in the postgenomic era. Ultimately, we outline a roadmap to guide future developments in glycomics envisaging clinical implementation.
DOI: 10.1016/j.ceb.2011.05.001
发表时间: 2011-08-01
影响因子: 7.5
作者:
Boscher, Cecile;Dennis, James W.;Nabi, Ivan R.
通讯作者: Nabi, Ivan R.
DOI: 10.1073/pnas.0906549106
发表时间: 2009-08-18
影响因子: 11.1
作者:
Chan, Keith Syson;Espinosa, Inigo;Weissman, Irving L.
通讯作者: Weissman, Irving L.
DOI: 10.1038/labinvest.3700268
发表时间: 2005-07-01
影响因子: 5
作者:
Chihara, Y;Sugano, K;Hirao, Y
通讯作者: Hirao, Y
DOI: 10.1007/s13277-010-0033-9
发表时间: 2010-08-01
期刊: TUMOR BIOLOGY
影响因子: --
作者:
Canesin, Giacomo;Gonzalez-Peramato, Pilar;Sanchez-Carbayo, Marta
通讯作者: Sanchez-Carbayo, Marta
DOI: 10.1016/j.molonc.2014.02.008
发表时间: 2014-05-01
期刊: MOLECULAR ONCOLOGY
影响因子: 6.6
作者:
Carrascal, Mylene A.;Severino, Paulo F.;Videira, Paula A.
通讯作者: Videira, Paula A.